Cigna Investments’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-877
Closed -$249K 484
2022
Q1
$249K Sell
877
-269
-23% -$82.9K 0.03% 503
2021
Q4
$431K Sell
1,146
-503
-31% -$195K 0.03% 412
2021
Q3
$681K Hold
1,649
0.05% 336
2021
Q2
$611K Sell
1,649
-300
-15% -$100K 0.04% 378
2021
Q1
$565K Buy
1,949
+158
+9% +$43.9K 0.04% 412
2020
Q4
$447K Buy
1,791
+175
+11% +$41.7K 0.03% 443
2020
Q3
$366K Hold
1,616
0.04% 433
2020
Q2
$282K Buy
+1,616
New +$258K 0.03% 565
2019
Q2
Sell
-1,384
Closed -$201K 672
2019
Q1
$201K Buy
+1,384
New +$182K 0.02% 646
2017
Q4
Sell
-1,903
Closed -$206K 900
2017
Q3
$206K Buy
+1,903
New +$196K 0.01% 830

Other funds holding CRL